Matthew Hawryluk
Director/Board Member en PREDICTIVE ONCOLOGY INC. .
Fortuna: 761 476 $ al 31/03/2024
Perfil
Matthew J.
Hawryluk is an Independent Director at Predictive Oncology, Inc. and the Chief Business Officer & Executive Vice President at Gritstone bio, Inc. He was previously the Vice President-Corporate & Business Development at Foundation Medicine, Inc. Hawryluk received his undergraduate degree from the University of Notre Dame, his MBA from the Tepper School of Business, and his doctorate from the University of Pittsburgh School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GRITSTONE BIO, INC.
0.29% | 01/02/2024 | 286 880 ( 0.29% ) | 737 282 $ | 31/03/2024 |
PREDICTIVE ONCOLOGY INC
0.23% | 05/04/2024 | 9 488 ( 0.23% ) | 24 194 $ | 31/03/2024 |
Cargos activos de Matthew Hawryluk
| Empresas | Cargo | Inicio |
|---|---|---|
| GRITSTONE BIO, INC. | Corporate Officer/Principal | 01/11/2015 |
| PREDICTIVE ONCOLOGY INC. | Director/Board Member | 29/11/2022 |
Antiguos cargos conocidos de Matthew Hawryluk.
| Empresas | Cargo | Fin |
|---|---|---|
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | - |
Formación de Matthew Hawryluk.
| University of Notre Dame | Undergraduate Degree |
| Tepper School of Business | Masters Business Admin |
| University of Pittsburgh School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| GRITSTONE BIO, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
- Bolsa de valores
- Insiders
- Matthew Hawryluk
